Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation.
暂无分享,去创建一个
P. Caron | M. Crépin | N. Porchet | A. Vincent | P. Pigny | Catherine Cardot Bauters | V. D. De Montpreville | Monelle Bertrand | Audrey Vincent
[1] M. Perrais,et al. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells , 2007, Oncogene.
[2] M. Negrini,et al. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour. , 2007, Human molecular genetics.
[3] A. Gabory,et al. The H19 gene: regulation and function of a non-coding RNA , 2006, Cytogenetic and Genome Research.
[4] P. Dahia. Evolving concepts in pheochromocytoma and paraganglioma , 2006, Current opinion in oncology.
[5] M. Mascalchi,et al. Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X , 2005, Journal of Medical Genetics.
[6] H. Spencer,et al. A census of mammalian imprinting. , 2005, Trends in genetics : TIG.
[7] B. Baysal. Genomic imprinting and environment in hereditary paraganglioma , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.
[8] Maria Vernucci,et al. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome , 2004, Nature Genetics.
[9] E. Jordanova,et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families , 2004, Oncogene.
[10] K. Sotlar,et al. Chromosome 11 monosomy in conjunction with a mutated SDHD initiation codon in nonfamilial paraganglioma cases. , 2004, Cancer genetics and cytogenetics.
[11] M. Fraga,et al. Genetic and epigenetic profile of sporadic pheochromocytomas , 2004, Journal of Medical Genetics.
[12] B. Baysal. On the association of succinate dehydrogenase mutations with hereditary paraganglioma , 2003, Trends in Endocrinology & Metabolism.
[13] C. Aston,et al. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect , 2003, Human Genetics.
[14] E. Leteurtre,et al. Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes , 2003, Journal of medical genetics.
[15] J. Benítez,et al. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma , 2002, European Journal of Human Genetics.
[16] W. Rubinstein,et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas , 2002, Journal of medical genetics.
[17] P. Rustin,et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.
[18] C. Eng,et al. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. , 2000, Cancer research.
[19] B. Devlin,et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.
[20] P. Heikkilä,et al. Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells. , 1997, The Journal of clinical endocrinology and metabolism.
[21] P. Maaswinkel-Mooy,et al. GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY , 1989, The Lancet.